scholarly journals Primary lateral sclerosis-like picture in a patient with a remote history of anti-N-methyl-D- aspartate receptor (anti-NMDAR) antibody encephalitis

2018 ◽  
pp. bcr-2017-224060
Author(s):  
Mubeen Janmohamed ◽  
Wally Knezevic ◽  
Merrilee Needham ◽  
Sam Salman
Neurology ◽  
2006 ◽  
Vol 66 (5) ◽  
pp. 647-653 ◽  
Author(s):  
P. H. Gordon ◽  
B. Cheng ◽  
I. B. Katz ◽  
M. Pinto ◽  
A. P. Hays ◽  
...  

Neurology ◽  
2021 ◽  
Vol 96 (17) ◽  
pp. e2231-e2238 ◽  
Author(s):  
Anhar Hassan ◽  
Shivam Om Mittal ◽  
William T. Hu ◽  
Keith A. Josephs ◽  
Eric J. Sorenson ◽  
...  

ObjectiveTo assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up.MethodsRetrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990–2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms.ResultsForty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38–78 years) and median follow-up at 9 years’ disease duration (range 4–36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; p = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs.ConclusionsPure PLS did not convert to ALS after a median of 9 years’ disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, <5% develop a more pervasive neurodegenerative disorder.


Author(s):  
Konstantin Gulyabin

Mills' syndrome is a rare neurological disorder. Its nosological nature is currently not completely determined. Nevertheless, Mills' syndrome is considered to be a rare variant of the degenerative pathology of the central nervous system – a variant of focal cortical atrophy. The true prevalence of this pathology is unknown, since this condition is more often of a syndrome type, observed in the clinical picture of a number of neurological diseases (primary lateral sclerosis, frontotemporal dementia, etc.) and is less common in isolated form.


2020 ◽  
Vol 21 (sup1) ◽  
pp. 18-27
Author(s):  
Erik P. Pioro ◽  
Martin R. Turner ◽  
Peter Bede

Author(s):  
Eoin Finegan ◽  
Stacey Li Hi Shing ◽  
Rangariroyashe H. Chipika ◽  
Kai Ming Chang ◽  
Mary Clare McKenna ◽  
...  

2012 ◽  
Vol 72 (4) ◽  
pp. 510-516 ◽  
Author(s):  
Amr Al-Saif ◽  
Saeed Bohlega ◽  
Futwan Al-Mohanna

2020 ◽  
Vol 21 (sup1) ◽  
pp. 28-34
Author(s):  
Vincenzo Silani ◽  
Philippe Corcia ◽  
Matthew B. Harms ◽  
Guy Rouleau ◽  
Teepu Siddique ◽  
...  

Author(s):  
Claire Kariya ◽  
Lisa Vardi

Adults with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) may develop swallowing difficulties and elect to receive an enterostomy feeding tube for nutrition support. Blenderized tube feeding (BTF) appeals to those interested in a homemade enteral nutrition option, but there are concerns of feeding tube occlusion and limited research on this potential risk. Therefore, our purpose was to determine the frequency of, and risk factors for, feeding tube occlusions among adults with ALS or PLS who use BTF. For this retrospective study, the electronic medical records of tube-fed adults with ALS or PLS who received outpatient care at a provincial ALS clinic during a two-year period were reviewed (n = 651). There were 97 tube-fed patients identified, of which 20 (21%) used BTF. Average duration of BTF use was 11.25 ± 7.5 months. Seven subjects (35%) used BTF exclusively, while 13 (65%) used a combination of BTF and commercial enteral formula. All received BTF by gastrostomy tube, sized 14 to 24 French. BTF administration methods and compliance with water flush recommendations varied. Despite the perceived risk of feeding tube occlusions with blenderized tube feeding, no occlusions were found to have occurred in this study.


Sign in / Sign up

Export Citation Format

Share Document